Andrew John Phillips

Insider Reports History

Location
Boston, MA
Signature
/s/ Matthias Bodenstedt, Attorney-in-fact for Andrew John Phillips
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew John Phillips:

Company Role Class Num Shares Value Price $ Report Date Ownership
Enliven Therapeutics, Inc. Director Stock Option (right to buy) 20,491 06 Feb 2025 Direct
OnKure Therapeutics, Inc. Director Stock Option (right to buy) 7,650 28 May 2025 Direct
MoonLake Immunotherapeutics Director Option to Buy 6,682 05 Jun 2025 Direct

Insider Reports Filed by Andrew John Phillips

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MLTX MoonLake Immunotherapeutics 05 Jun 2025 1 $0 4 Director 09 Jun 2025, 09:05
OKUR OnKure Therapeutics, Inc. 28 May 2025 1 $0 4 Director 30 May 2025, 16:54
ELVN Enliven Therapeutics, Inc. 06 Feb 2025 1 $0 4 Director 10 Feb 2025, 17:40
OKUR OnKure Therapeutics, Inc. 04 Oct 2024 1 $0 4 Director 08 Oct 2024, 19:28
OKUR OnKure Therapeutics, Inc. 04 Oct 2024 0 $0 3 Director 08 Oct 2024, 19:12
MLTX MoonLake Immunotherapeutics 06 Jun 2024 1 $0 4 Director 07 Jun 2024, 17:00
ELVN Enliven Therapeutics, Inc. 13 Feb 2024 1 $0 4/A Director 20 Feb 2024, 19:35
ELVN Enliven Therapeutics, Inc. 13 Feb 2024 1 $0 4 Director 15 Feb 2024, 21:04
MLTX MoonLake Immunotherapeutics 08 Jun 2023 1 $0 4 Director 12 Jun 2023, 16:47
ELVN Enliven Therapeutics, Inc. 23 Feb 2023 1 $0 4 Director 06 Apr 2023, 20:20
ELVN Enliven Therapeutics, Inc. 23 Feb 2023 0 $0 3 Director 27 Feb 2023, 20:49
MLTX MoonLake Immunotherapeutics 06 Apr 2022 1 $0 4 Director 05 May 2022, 17:45
MLTX MoonLake Immunotherapeutics 05 Apr 2022 0 $0 3 Director 15 Apr 2022, 16:06